Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN85524728
ISRCTN85524728
Active, not recruiting
未知

Comparison of devices for the detection of diabetic neuropathy; an evaluative diagnostic study. (short title: ‘MANDARIN’ , Medipin Assessment for Neuropathy in Diabetes, A Real-world INvestigation)

orth Cumbria Integrated Care NHS Foundation Trust0 sites139 target enrollmentAugust 24, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDiabetic neuropathyNutritional, Metabolic, Endocrine

Overview

Phase
未知
Intervention
Not specified
Conditions
Diabetic neuropathy
Sponsor
orth Cumbria Integrated Care NHS Foundation Trust
Enrollment
139
Status
Active, not recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 24, 2023
End Date
December 31, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
orth Cumbria Integrated Care NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • •1\. Adult patients aged \>\=18 years
  • •2\. Patients with type II diabetes mellitus

Exclusion Criteria

  • •1\. Aged \<18 years
  • •2\. Any reasons for the patient being unable to follow the protocol, including lack of mental capacity to consent to taking part in the study (examples include dementia, severe learning disability).
  • •3\. The patient has concurrent (medical) conditions that in the opinion of the investigator may compromise patient safety or study objectives (examples include receiving palliative care, active cancer treatment, patient immobile)
  • •4\. Amputation of a lower limb
  • •5\. Confirmed and ongoing wound/ulcer located on the foot

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Evaluation of a tool to predict technology usage in youth with type 1 diabetes.Type 1 diabetes mellitusMetabolic and Endocrine - Diabetes
ACTRN12611001043921The Royal Childrens Hospital100
Recruiting
Phase 4
The comparison of blood glucose profile of diabetic patients who change Insulin Glargine to Insulin Degludec as basal insulin.Diabetes
JPRN-UMIN000009627Diabetes Therapeutics and Research Center, The University of Tokushima25
Suspended
Not Applicable
Concordance of Hypoglycemia Measurement With Simultaneous Use of Two Devices for Continuous Glucose Measurement.Type 1 DiabetesHypoglycemia
NCT06246578Central Jutland Regional Hospital14
Completed
Not Applicable
Standardized Procedure for the Assessment of New-to-market Continuous Glucose Monitoring SystemsDiabetes Mellitus
NCT01751932Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)24
Not yet recruiting
Not Applicable
Comparison of efficacy of metformin plus dapagliflozin versus metformin plus insulin sensitizer in patients having diabetes mellitus type-2 in Pakistan.
ACTRN12622000243718Dr. Malik Hassan Mehmood84